Point72 Middle East FZE’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,400
Closed -$153K 854
2023
Q4
$153K Sell
1,400
-11,200
-89% -$1.16M ﹤0.01% 1106
2023
Q3
$1.3M Buy
12,600
+300
+2% +$32.3K 0.04% 487
2023
Q2
$1.42M Buy
12,300
+3,400
+38% +$386K 0.04% 478
2023
Q1
$947K Sell
8,900
-27,800
-76% -$3M 0.03% 517
2022
Q4
$4.07M Buy
+36,700
New +$3.75M 0.18% 137

Other funds holding MRK

Point72 Middle East FZE's MRK Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Merck (MRK) in Q1 2024, closing a stake of 29,323 shares — an estimated $3.2M sold.

Point72 Middle East FZE first reported a position in MRK in Q4 2022 and held it in 4 quarters. The position peaked at $26M in Q3 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 29,323 Merck shares in Q1 2024, an estimated $3.2M.
  • Point72 Middle East FZE first reported a position in Merck in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Merck position peaked at $26M in Q3 2023.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.